Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Delayed Quote USD

Enlivex Therapeutics Ltd. (ENLV)

Compare
0.8975
-0.0198
(-2.16%)
At close: April 11 at 4:00:01 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for ENLV

Recent News: ENLV

View More
Is Enlivex Therapeutics (NASDAQ:ENLV) In A Good Position To Invest In Growth?

Is Enlivex Therapeutics (NASDAQ:ENLV) In A Good Position To Invest In Growth?
Simply Wall St. 4 days ago
Enlivex Announces the Dosing of the First Patient in a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis

Enlivex Announces the Dosing of the First Patient in a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis
GlobeNewswire 8 days ago
Enlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis

Enlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis
GlobeNewswire 25 days ago
Enlivex Therapeutics Announces Investor Webinar to Discuss Positive Interim Data from Phase I/II Allocetra™ Trial in Knee Osteoarthritis

Enlivex Therapeutics Announces Investor Webinar to Discuss Positive Interim Data from Phase I/II Allocetra™ Trial in Knee Osteoarthritis
GlobeNewswire last month
Enlivex Announces Positive Interim Data – Statistically Significant 47.0% Durable and Persistent Pain Reduction At Six Months, in Patients with Moderate to Severe Knee Osteoarthritis

Enlivex Announces Positive Interim Data – Statistically Significant 47.0% Durable and Persistent Pain Reduction At Six Months, in Patients with Moderate to Severe Knee Osteoarthritis
GlobeNewswire last month
Enlivex Issues Urgent Statement on Fraudulent News Dissemination

Enlivex Issues Urgent Statement on Fraudulent News Dissemination
GlobeNewswire last month
RedChip Announces Webinar to Teach Investors How to Use RedChat, a Revolutionary AI Chatbot for Small-Cap Stock Analysis

RedChip Announces Webinar to Teach Investors How to Use RedChat, a Revolutionary AI Chatbot for Small-Cap Stock Analysis
ACCESS Newswire last month
Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ACCESS Newswire 2 months ago
Enlivex gains Israeli regulatory approval to commence TMJ osteoarthritis trial

Enlivex gains Israeli regulatory approval to commence TMJ osteoarthritis trial
Clinical Trials Arena 3 months ago
Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis

Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis
GlobeNewswire 3 months ago
Enlivex Announces Positive Interim Efficacy Data from Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis

Enlivex Announces Positive Interim Efficacy Data from Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis
GlobeNewswire 4 months ago
View More

Related Tickers

BONS.TA Bonus BioGroup Ltd.
16.50
+12.24%
 
CANF Can-Fite BioPharma Ltd.
1.5700
+12.30%
 
PLUR Pluri Inc.
3.8150
+2.01%
 
BLRX BioLineRx Ltd.
2.7500
+13.17%
 
ENTX Entera Bio Ltd.
1.6900
0.00%
 
NRSN NeuroSense Therapeutics Ltd.
1.0600
+8.16%
 
CGEN Compugen Ltd.
1.2600
+4.13%
 
ORMP Oramed Pharmaceuticals Inc.
2.1100
-0.94%
 
CLGN CollPlant Biotechnologies Ltd.
2.4377
-2.10%
 
PYPD PolyPid Ltd.
2.4800
-0.60%